{"doi":"10.1188/20.onf.557-566","title":"Skeletal Muscle Mass Loss During Cancer Treatment: Differences by Race and Cancer Site","abstract":"OBJECTIVES: To examine skeletal muscle mass change in a racially diverse sample of patients undergoing cancer treatment, determine significant predictors of muscle mass loss, and explore the interaction of race and cancer site. SAMPLE &AMP; SETTING: A retrospective analysis was conducted for 212 patients seeking treatment at a university hospital clinic. METHODS &AMP; VARIABLES: Skeletal muscle mass index (SMI) was determined by computed tomography at the time of cancer diagnosis and with cancer treatment. RESULTS: One hundred thirty-four patients (63%) had SMI loss with cancer treatment. Race and cancer site were found to be significant predictors of SMI loss. Compared to other racial groups, non-Hispanic Black (NHB) patients had the greatest SMI loss (p < 0.001) with cancer treatment. NHB patients with rectal cancer experienced the greatest SMI loss compared to patients of other races and cancer types. IMPLICATIONS FOR NURSING: To improve survivorship care for patients with cancer, it is essential to develop strategies for assessing and managing skeletal muscle mass loss throughout treatment, particularly for NHB patients with rectal cancer.","journal":"Oncology nursing forum","year":2020,"id":107484,"datarank":0.29188652235829704,"base_score":1.9459101490553132,"endowment":1.9459101490553132,"self_citation_contribution":0.29188652235829704,"citation_network_contribution":0.0,"self_endowment_contribution":0.29188652235829704,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":6,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.7036,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":516535,"name":"Chang Gi Park","orcid":"0000-0003-3366-4279","position":1,"is_corresponding":false},{"id":517135,"name":"Susan Hong","orcid":null,"position":2,"is_corresponding":false},{"id":502638,"name":"Deepika Laddu","orcid":"0000-0001-6790-0220","position":3,"is_corresponding":false},{"id":516536,"name":"Hongjin Li","orcid":"0000-0002-5466-1192","position":4,"is_corresponding":false},{"id":517136,"name":"Esther Rhee","orcid":null,"position":5,"is_corresponding":false},{"id":286146,"name":"Ardith Z. Doorenbos","orcid":"0000-0002-3899-8238","position":6,"is_corresponding":false},{"id":286147,"name":"Min Kyeong Jang","orcid":"0000-0002-6073-161X","position":0,"is_corresponding":true}],"reference_count":47,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-18T23:12:34.898963Z","pmid":"32830799","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}